Xvivo Perfusion AB (CHIX:XVIVOS) Non Operating Income: kr0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:XVIVOS Xvivo Perfusion AB CHIX:XVIVOS
84 GF Score
Price kr302.60
GF Value kr448.87
! 3 Warning Signs
View Full Analysis

What is Xvivo Perfusion AB Non Operating Income?

Xvivo Perfusion AB CHIX:XVIVOS 84 Non Operating Income is kr0.0 Mil as of Jun. 2026. GuruFocus rates CHIX:XVIVOS with a GF Score™ of 84/100 and a GF Value™ of kr448.87. The stock has 3 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Xvivo Perfusion AB's Non Operating Income for the three months ended in Jun. 2026 was kr0.0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.0 Mil.

Xvivo Perfusion AB Non Operating Income Related Terms

Xvivo Perfusion AB Non Operating Income Historical Data

* Premium members only.

The historical data trend for Xvivo Perfusion AB's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xvivo Perfusion AB Non Operating Income Chart

Xvivo Perfusion AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xvivo Perfusion AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:XVIVOS
84GF Score
Xvivo Perfusion AB CHIX:XVIVOS
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xvivo Perfusion AB Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of kr0.0 Mil mean?
Xvivo Perfusion AB (CHIX:XVIVOS) has a Non Operating Income of kr0.0 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Xvivo Perfusion AB and its competitors.
Is Xvivo Perfusion AB's Non Operating Income too high?
Xvivo Perfusion AB's current Non Operating Income is kr0.0 Mil. Overall, Xvivo Perfusion AB has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Xvivo Perfusion AB's Non Operating Income compare to ABT and SYK?
Xvivo Perfusion AB's Non Operating Income of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Xvivo Perfusion AB and its competitors. Xvivo Perfusion AB's current Non Operating Income is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xvivo Perfusion AB stock overvalued right now?
Xvivo Perfusion AB (CHIX:XVIVOS) has a current Non Operating Income of kr0.0 Mil. The stock's GF Value™ is kr448.87, compared to a current price of kr302.60 — trading 32.6% below its estimated fair value. The current Non Operating Income is kr0.0 Mil. Xvivo Perfusion AB's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Xvivo Perfusion AB (CHIX:XVIVOS), the current Non Operating Income is kr0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xvivo Perfusion AB (CHIX:XVIVOS) Overvalued in 2026?

Based on GuruFocus' analysis, Xvivo Perfusion AB stock appears to be undervalued. The current stock price of kr302.60 is trading 32.6% below its estimated GF Value™ of kr448.87.

Key valuation signals for CHIX:XVIVOS:

  • Non Operating Income: kr0.0 Mil
  • GF Value™: kr448.87 vs. price of kr302.60 (32.6% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the CHIX:XVIVOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xvivo Perfusion AB Business Description

Address Gemenskapens gata 9, Molndal, SWE, SE-431 53
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments, namely Thoracic: sales of lung and heart transplant products; Abdominal: sales of liver and kidney transplant products and perfusion services; and Services: revenue from the sale of services related to organ recovery, as well as digital products for communication and workflow management at transplantation clinics. The majority of revenue is derived from the Thoracic segment, and geographically, the majority is from the United States.
84GF Score

Get the complete analysis for CHIX:XVIVOS

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr302.60
Price
kr448.87
GF Value